GlaxoSmithKline, WHO/TDR and the Medicines for Malaria Venture collaborate to fight malaria

To develop a new-fixed dose artemisinin combination therapy drug (ACT) for the treament of malaria

23 Apr 2004

Attachments

View press release (English) [141.43 KB]

pdf - 141.43 KB

Communiqué de presse (en français) [151.1 KB]

pdf - 151.1 KB